Please login to the form below

Not currently logged in
Email:
Password:

liver disease

This page shows the latest liver disease news and features for those working in and with pharma, biotech and healthcare.

Viking throws downn gauntlet in NASH battle

Viking throws downn gauntlet in NASH battle

Viking throws downn gauntlet in NASH battle. Biotech is challenging rival Madrigal in 'next big thing' disease area. ... weeks’treatment, tackling one of the main biomarkers for NASH and other forms of non-alcoholic fatty liver disease (NAFLD), and

Latest news

More from news
Approximately 9 fully matching, plus 88 partially matching documents found.

Latest Intelligence

  • Gene therapy Gene therapy

    This is reflected in the large number of companies focusing on liver disease, as liposomal delivery vehicles tend to accumulate in the liver, or where the mode of delivery offers targeting ... targets. The overt focus on liver disease has led to one new

  • Deal Watch April 2016 Deal Watch April 2016

    265 . Intellia (US). Regeneron (US). Co-development &co-commercialisation. Discovery stage CRISPR/Cas platform for treatments of liver disease. ... 72 . Synta (US). Madrigal (US). Company acquisition. Phase I compound for treatment of liver disease.

  • AbbVie: New firm, new thinking AbbVie: New firm, new thinking

    And obviously the NHS saves on downstream costs associated with HCV, such as liver disease and the prospect of liver transplants. ... Liver disease is still one of the biggest killers in the UK and it's the only one of the top five that's actually not

  • Case study: Liver disease burden Case study: Liver disease burden

    out to and engage with stakeholders who can lead the way in addressing liver disease. ... As a result the All-Party Parliamentary Hepatology Group (APPHG) conducted an expert inquiry into liver disease.

  • Case study: Liver disease burden Case study: Liver disease burden

    out to and engage with stakeholders who can lead the way in addressing liver disease. ... As a result the All-Party Parliamentary Hepatology Group (APPHG) conducted an expert inquiry into liver disease.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences

    manage this disease.”. ... Shailubhai takes the helm as Tiziana focuses on developing an orally administered, anti-CD3 mAb (foalumab) drug candidate to manage non-alcoholic steatohepatitis (NASH) - a liver disease that has no treatment

  • GLI names VP of scientific and regulatory affairs GLI names VP of scientific and regulatory affairs

    Food and Drug Administration and at several leading pharmaceutical companies, he brings to GLI extensive industry experience that will help us identify opportunities to transform the field of liver disease.”. ... Liver disease affects over 30 million

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Living with NASH: An Unexpected Diagnosis

    With no current licensed treatments and more than 20 compounds in phase II and III, the liver disease non-alcoholic steatohepatitis (NASH) represents a huge opportunity for pharma companies – if they ... And, because it’ s relatively unknown,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics